A clinical trial is a voluntary human research study conducted in humans to determine the safety and effectiveness of an investigational drug in a particular disease. These trials are carefully controlled and are important in identifying new treatment options for patients with diseases such as cancer, including prostate cancer.
Cancer patients who participated in a study conducted by the Coalition of Cancer Cooperative Groups reported they were very satisfied with their experience. Overall 91% indicated they would recommend participating in a trial to a friend and 92% had a positive experience.
Clovis Oncology is conducting clinical trials with the PARP inhibitor rucaparib to test it in men with metastatic castration-resistant prostate cancer (mCRPC).
Ask your healthcare professionals for more information about clinical trials or read more about clinical trials at:
The American Society of Clinical Oncology also has a series of videos, Preparatory Education About Clinical Trials (PRE-ACT), addressing common questions about clinical trials: